MATINAS BIOPHARMA HOLDINGS, INC. Operating Lease, Lease Income, Lease Payments
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) reported Operating Lease, Lease Income, Lease Payments of $169.58 thousand for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-13.
Discontinued › Income Statement › Other Income
us-gaap:OperatingLeaseLeaseIncomeLeasePayments · last filed 2019-08-13
- MATINAS BIOPHARMA HOLDINGS, INC. operating lease, lease income, lease payments for the quarter ending 2019-06-30 was $253.37K.
- MATINAS BIOPHARMA HOLDINGS, INC. operating lease, lease income, lease payments for the quarter ending 2019-03-31 was -$83.79K.
| Period end | Operating Lease, Lease Income, Lease Payments 3 month | Operating Lease, Lease Income, Lease Payments 6 month |
|---|---|---|
| 2019-06-30 | $253.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $169.58K 10-Q · filed 2019-08-13 |
| 2019-03-31 | -$83.79K 10-Q · filed 2019-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |